METADOL-D DIN 02247693
Health Canada record
| Active ingredient(s) | METHADONE HYDROCHLORIDE 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N07BC02 METHADONE |
| Original market date | |
| Current status date | 28-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Paladin Pharma Inc. — licence 100234, currently licensed, last inspection rating C (2023-04-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHADONE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02533669 | APO-METHADONE | APOTEX INC | Tablet | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02533642 | APO-METHADONE | APOTEX INC | Tablet | METHADONE HYDROCHLORIDE 1 MG | Marketed |
| 02533677 | APO-METHADONE | APOTEX INC | Tablet | METHADONE HYDROCHLORIDE 25 MG | Marketed |
| 02533650 | APO-METHADONE | APOTEX INC | Tablet | METHADONE HYDROCHLORIDE 5 MG | Marketed |
| 02496658 | COMFORTAN | EUROVET ANIMAL HEALTH B.V. | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02495783 | JAMP METHADONE ORAL CONCENTRATE | JAMP PHARMA CORPORATION | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02247700 | METADOL | KNIGHT THERAPEUTICS INC. | Tablet | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02247694 | METADOL | KNIGHT THERAPEUTICS INC. | Solution | METHADONE HYDROCHLORIDE 1 MG | Marketed |
| 02241377 | METADOL | KNIGHT THERAPEUTICS INC. | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02247698 | METADOL | KNIGHT THERAPEUTICS INC. | Tablet | METHADONE HYDROCHLORIDE 1 MG | Marketed |
| 02247699 | METADOL | KNIGHT THERAPEUTICS INC. | Tablet | METHADONE HYDROCHLORIDE 5 MG | Marketed |
| 02247701 | METADOL | KNIGHT THERAPEUTICS INC. | Tablet | METHADONE HYDROCHLORIDE 25 MG | Marketed |
| 02247374 | METADOL-D | KNIGHT THERAPEUTICS INC. | Solution | METHADONE HYDROCHLORIDE 1 MG | Marketed |
| 02244290 | METADOL-D | KNIGHT THERAPEUTICS INC. | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02481979 | METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP | STERINOVA INC. | Solution | METHADONE HYDROCHLORIDE 10 MG | Approved |
| 02394596 | METHADOSE | MALLINCKRODT CANADA ULC | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02394618 | METHADOSE | MALLINCKRODT CANADA ULC | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02495872 | ODAN-METHADONE | ODAN LABORATORIESLTD | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02495880 | ODAN-METHADONE | ODAN LABORATORIESLTD | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02552736 | PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE | PHARMASCIENCE INC | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02552728 | PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE | PHARMASCIENCE INC | Solution | METHADONE HYDROCHLORIDE 10 MG | Marketed |
| 02247697 | METADOL-D | PALADIN PHARMA INC. | Tablet | METHADONE HYDROCHLORIDE 25 MG | Cancelled Pre Market |
| 02247696 | METADOL-D | PALADIN PHARMA INC. | Tablet | METHADONE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02247695 | METADOL-D | PALADIN PHARMA INC. | Tablet | METHADONE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02388405 | PMS-METHADONE | ENDO OPERATIONS LTD. | Tablet | METHADONE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02388413 | PMS-METHADONE | ENDO OPERATIONS LTD. | Tablet | METHADONE HYDROCHLORIDE 25 MG | Cancelled Pre Market |
| 02388391 | PMS-METHADONE | ENDO OPERATIONS LTD. | Tablet | METHADONE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02388383 | PMS-METHADONE | ENDO OPERATIONS LTD. | Tablet | METHADONE HYDROCHLORIDE 1 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15318 | 2014-02-25 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
| 2833 | 2003-07-11 | Supplement to a New Drug Submission (SNDS) | NEW DOSAGE FORM: 1MG, 5MG, 10MG, 25MG TABLETS |
International API supply for METHADONE HYDROCHLORIDE
6 valid EDQM Certificates of Suitability from 6 holders. 4 active FDA Drug Master Files.
Request a quote for METADOL-D